Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma
NCT05006469
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Bendamustine
Multiple Myeloma
Interventions
DRUG:
Bendamustine
Sponsor
Liao Aijun